NervGen Pharma Corp. (NGEN)

NervGen Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.07	17.27	11.66	22.45	16.93
Cash & Short-Term Investments	22.07	17.27	11.66	22.45	16.93
Cash Growth	27.81%	48.10%	-48.07%	32.62%	202.38%
Accounts Receivable	0.01	0.1	-	-	-
Other Receivables	0.08	0.42	0.25	0.03	0.06
Receivables	0.09	0.51	0.25	0.03	0.06
Prepaid Expenses	0.39	0.29	0.11	0.08	0.07
Other Current Assets	0.25	0.94	0.5	0.59	0.36
Total Current Assets	22.8	19.01	12.52	23.15	17.42
Property, Plant & Equipment	-	-	0.2	0.3	0
Other Intangible Assets	0.41	0.46	0.52	0.43	0.47
Long-Term Accounts Receivable	-	0.01	-	-	-
Total Assets	23.21	19.49	13.24	23.88	17.9
Accounts Payable	0.03	0.03	3.32	2	0.35
Accrued Expenses	4.63	4.91	-	1.4	0.73
Current Portion of Leases	0.01	0.1	0.09	0.09	-
Other Current Liabilities	15.07	11.86	11.73	6.73	-
Total Current Liabilities	19.73	16.9	15.14	10.22	1.08
Long-Term Leases	-	0.01	0.11	0.2	-
Total Liabilities	19.73	16.91	15.25	10.41	1.08
Common Stock	103	81.19	58.93	57.41	42.4
Retained Earnings	-146.76	-102.65	-78.15	-55.77	-35.05
Comprehensive Income & Other	47.24	24.03	17.21	11.82	9.46
Shareholders' Equity	3.48	2.58	-2.01	13.46	16.82
Total Liabilities & Equity	23.21	19.49	13.24	23.88	17.9
Total Debt	0.01	0.11	0.2	0.28	-
Net Cash (Debt)	22.06	17.16	11.46	22.17	16.93
Net Cash Growth	28.55%	49.72%	-48.29%	30.95%	202.38%
Net Cash Per Share	0.30	0.25	0.19	0.42	0.43
Filing Date Shares Outstanding	80.93	70.99	69.93	59.13	46.23
Total Common Shares Outstanding	79.65	70.33	59.61	58.78	46.19
Working Capital	3.07	2.11	-2.62	12.93	16.34
Book Value Per Share	0.04	0.04	-0.03	0.23	0.36
Tangible Book Value	3.07	2.11	-2.53	13.03	16.35
Tangible Book Value Per Share	0.04	0.03	-0.04	0.22	0.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.